# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 4


In regulation 7 (amendment of regulation 5 (classification of medicinal products))—
(a) for paragraph (2) substitute—
“(2) In paragraph (1)(b), before “a product that” insert “in the case of a medicinal product for sale or supply in Northern Ireland,”.”;
(b) in paragraph (3)—
(i) omit sub-paragraph (a);
(ii) for sub-paragraph (b) substitute—
“(b) in sub-paragraph (d), before “an Article 126a” insert “in the case of a medicinal product for sale or supply in Northern Ireland,”.”;
(c) in paragraph (4)—
(i) for sub-paragraph (a) substitute—
“(a) in sub-paragraph (b), before “a medicinal product” insert “in the case of a medicinal product for sale or supply in Northern Ireland, ”;”;
(ii) omit sub-paragraph (b);
(d) in paragraph (5) for “omit sub-paragraph (b)” to the end substitute “in sub-paragraph (b), before “an Article” insert “in the case of a medicinal product for sale or supply in Northern Ireland,”.”; and
(e) in paragraph (6)—
(i) for sub-paragraph (a) substitute—
“(a) in sub-paragraph (b), before “a product that” insert “in the case of a medicinal product for sale or supply in Northern Ireland,”; and”; and
(ii) omit sub-paragraph (b).

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/4 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.